CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- 4 Grant or award Director acquired 161,374 shares (grant or award)
- 4 Grant or award Director acquired 161,374 shares (grant or award)
- 4 Grant or award Director acquired 161,374 shares (grant or award)
- 4 Other disposition CEO & President disposed of 158,017,321 shares (other)
- 4 Grant or award Director acquired 72,040 shares (grant or award)
- 4 Grant or award Director acquired 68,518 shares (grant or award)
- 4 Grant or award SVP of Operations acquired 110,849 shares (grant or award)
- 4 Grant or award Director acquired 133,019 shares (grant or award)
- 4 Grant or award Director acquired 88,679 shares (grant or award)
- 4 Grant or award Director acquired 88,679 shares (grant or award)
- 4 Grant or award CEO & President acquired 2,216,992 shares (grant or award)
- 4 Option exercise CEO & President acquired 142,857,143 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Conversion CFO, Secretary, Treasurer acquired 666,667 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Conversion Former Director acquired 4,000,000 shares (conversion)
- 4 Open-market sale former Chairman sold 570,520 shares at an average $0.34 ($196,055)
- 4 Open-market sale former Chairman sold 200,456 shares at an average $0.32 ($63,231)
- 4 Open-market sale former Chairman sold 909,878 shares at an average $0.33 ($301,266)
- 4 Grant or award Exec Vice Pres Operations acquired 47,767 shares (grant or award)
Page 3 of 26 · 511 filings